Patricia Beckmann

Founder/Managing Director, BioStrategy

Dr. Patricia Beckmann has an extensive background in science, law, commercial strategy and venture capital. She is CEO of Transduction Therapeutics and Managing Director of BioStrategy consulting. With over 30 years experience in the biopharma industry, Patricia believes biopharma should always emphasize patient needs first.

Patricia has held positions in research, administration and law at Immunex and Amgen (co-inventing EnbrelTM, peak worldwide sales ~$8B). At Vulcan Capital, she invested in biopharma companies and helped to establish the Allen Institute for Brain Sciences. She was CSO at Homestead Clinical (now Integrated Diagnostics) and Executive Director of Oregon Translational Research and Drug Development Institute (OTRADI) where she received the Commerce Department's i6 Challenge Award to establish the OTRADI bioscience-incubator. Patricia founded Life Science Washington Institute to foster bio-entrepreneur development.

Patricia is on the Board of Fe Pharmaceuticals, and previously was on the Boards of Cancer Research and Biostatistics, Drug and Device Advisory Council at the University of Washington, and Northwest Technology Ventures. She received a PhD in biochemistry/pharmacology and a BA in biology/chemistry and art. She twice received Fulbright Fellowships (Sweden/India), a Kauffman Fellowship, and a postdoc at the National Cancer Institute. She is an inventor on more than 40 U.S. Patents.